Adjunctive Intravitreal Anti-vascular Endothelial Growth Factor and Moxifloxacin Therapy in Management of Intraocular Tubercular Granulomas.
Manisha AgarwalChanda GuptaK Varsha MohanPramod K UpadhyayAditi DhawanVivek JhaPublished in: Ocular immunology and inflammation (2021)
; ATT: Antitubercular therapy; AMD: Age-related macular degeneration; SRF: Subretinal fluid; ELISA: Enzyme immunosorbent assay; PCR: Polymerase chain reaction; ONH: Optic nerve head; MDR-TB: Multidrug-resistant tuberculosis; pg/ml: picogram/milliliter; ESR: Erythrocyte sedimentation rate; CECT: Contrast enhanced computed tomography; DNA: Deoxyribonucleic acid; RNA: Ribonucleic acid; BSL: Biosafety level; BCVA: Best corrected visual acuity; HM: Hand movements; KP: Keratic precipitates; PSC: Posterior subcapsular cataract; PS: Posterior synechiae; CRA: Chorio-retinal atrophy; IVMP: Intravenous methyl prednisolone; OCT: Optical coherence tomography; RPE: Retinal pigment epithelium; FFA: Fundus fluorescein angiography; ICG: Indocyanine angiography; RAP: Retinal arterial proliferans.
Keyphrases
- optical coherence tomography
- optic nerve
- age related macular degeneration
- diabetic retinopathy
- vascular endothelial growth factor
- contrast enhanced
- computed tomography
- multidrug resistant
- magnetic resonance imaging
- diffusion weighted
- mycobacterium tuberculosis
- magnetic resonance
- gram negative
- positron emission tomography
- high dose
- endothelial cells
- high throughput
- drug resistant
- dual energy
- escherichia coli
- acinetobacter baumannii
- bone marrow
- emergency department
- diffusion weighted imaging
- low dose
- single molecule
- cell therapy
- mesenchymal stem cells
- cell free
- stem cells
- hepatitis c virus
- hiv aids
- monoclonal antibody
- pulmonary tuberculosis
- cataract surgery